Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin

Area of Science:

• Biophysics
• Structural Biology
• Antimicrobial Peptides

Background:

• Amphipathic alpha-helical peptides are known for antimicrobial activity, often linked to membrane pore formation.
• Direct structural evidence for membrane-bound states of these peptides, particularly transmembrane insertion, remains limited.
• Previous studies showed PGLa transitions between surface-bound states but not upright insertion.

Purpose of the Study:

• To investigate the structural basis of synergistic antimicrobial activity between PGLa and magainin 2.
• To determine if PGLa can adopt a transmembrane state in model membranes when mixed with magainin 2.
• To provide direct structural evidence for peptide-induced pore formation compatible with known models.

Main Methods:

• Solid-state deuterium (2)H-NMR spectroscopy was employed to analyze peptide structure and orientation in model membranes.
• Deuterium labeling was used for specific amino acid residues (Ala, Ile, Gly) to provide orientational constraints.
• Model membranes composed of dimyristoylphosphatidylcholine/dimyristoylphosphatidylglycerol were used at a low peptide-to-lipid ratio (1:100).

Main Results:

• PGLa, in a 1:1 mixture with magainin 2, adopted an upright transmembrane 'I-state' with a helix tilt of 158 degrees.
• This observation was supported by seven orientational constraints derived from (2)H-NMR analysis of labeled peptides.
• The formation of PGLa/magainin 2 heterodimers was rationalized as the cause for the observed transmembrane insertion.

Conclusions:

• This study provides the first direct structural evidence of an alpha-helical antimicrobial peptide (PGLa) assuming a transmembrane state.
• The findings support the formation of heterodimers as a mechanism for synergistic antimicrobial action.
• The observed transmembrane state is consistent with the proposed toroidal wormhole pore structure model for peptide-induced membrane disruption.